CPRI
Capri Holdings Limited
CPRI has the edge over TSLA overall, supported by stronger valuation and stronger modeled upside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
CPRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
CPRI's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
CPRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $14.12 | -31% |
| Forward | 9.4x | $20.38 | — |
| Current | 12x | $20.38 | — |
| Fair | 13x | $23.01 | +13% |
| Expensive | 21x | $36.91 | +81% |
Historical ranges are pointers, not guarantees.
CPRI has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
CPRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CPRI's earnings to grow and its profitability to improve, with its revenue holding steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
CPRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.17 | +23% |
| Q3 2026 | $1.77 | +$11.64 |
| Q2 2026 | $1.30 | +$10.75 |
| Q1 2026 | $1.14 | +$11.14 |
| Q4 2025 | -$4.30 | +$4.24 |
| Q3 2025 | -$9.87 | -$6.82 |
| Q2 2025 | -$9.45 | -$6.97 |
| Q1 2025 | -$10.00 | -$8.04 |
| Q4 2024 | -$8.54 | -547% |
CPRI has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
CPRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | -5.5% |
| Q2 2026 | $769M | -3.5% |
| Q1 2026 | $796M | -23% |
| Q4 2025 | $1B | -19% |
| Q3 2025 | $856M | -21% |
| Q2 2025 | $797M | -25% |
| Q1 2025 | $1B | -15% |
| Q4 2024 | $1.3B | -12% |
CPRI's revenue has slid since its 2021 peak: $809M last quarter, down 5.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.2% | +2.6 points |
| Q2 2026 | 2.2% | +0.2 points |
| Q1 2026 | -3.4% | +7.8 points |
| Q4 2025 | 4.5% | +51 points |
| Q3 2025 | -1.4% | +2.1 points |
| Q2 2025 | 2% | +2.8 points |
| Q1 2025 | -11% | +33 points |
| Q4 2024 | -47% | -55 points |
CPRI's operating margin was 1.2% last quarter, up 2.6 points from the same quarter a year ago.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over CPRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over CPRI on profitability, with a higher operating margin.
CPRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36M | +$101M |
| Q2 2026 | $48M | +$69M |
| Q1 2026 | -$83M | +$105M |
| Q4 2025 | $183M | -34% |
| Q3 2025 | -$65M | -383% |
| Q2 2025 | -$21M | -153% |
| Q1 2025 | -$188M | -$182M |
| Q4 2024 | $278M | -11% |
CPRI still generates free cash flow, though less than at its 2022 peak: $184M over the past year.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
CPRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.9% | -5.7M shares |
| 1 year | -7.9% | -9.4M shares |
| 3 years | -6.1% | -7.2M shares |
| 5 years | -28% | -43.9M shares |
| Available history | -27% | -41.8M shares |
CPRI has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $54M |
| Q1 2026 | $79M |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q2 2025 | $1M |
| Q1 2025 | — |
| Q4 2024 | — |
CPRI spent $283M buying back its own shares over the past year, more than ten times what it spent the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
CPRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2023 | 3.9x | Elevated |
| Q3 2023 | 3.6x | Elevated |
| Q2 2023 | 2.5x | Moderate |
| Q1 2023 | 1.9x | Healthy |
CPRI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.9 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over CPRI on leverage, with a lower net debt burden relative to earnings.
CPRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 88.5 | Overbought |
CPRI's weekly RSI is 64 (neutral) and its Stochastic is 88 (overbought).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
CPRI PE vs Consumer Cyclical Sector
| Metric | CPRI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 36% below |
| PE % | 43 | 47 | 4 pts below |
CPRI has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
CPRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 20% above |
| 20 week MA | $16.0 | 27% above |
| 50 week MA | $19.1 | 6.9% above |
| 100 week MA | $19.5 | 4.5% above |
| 200 week MA | $30.6 | 33% below |
CPRI has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 33% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over CPRI on trend strength, trading above more of its moving averages.
CPRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.5 | $42.4 | +13% |
| 2021 | $42.4 | $61.7 | +45% |
| 2022 | $61.7 | $55.7 | -9.7% |
| 2023 | $55.7 | $50.2 | -9.8% |
| 2024 | $50.2 | $21.0 | -58% |
| 2025 | $21.0 | $25.0 | +19% |
| 2026 YTD | $25.0 | $20.4 | -18% |
CPRI has finished lower in three of the last six years. It's down 18% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over CPRI on returns for 2026, with the stronger performance.